+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Point-of-Care Diagnostics Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Product (Glucose Monitoring Products, Infectious Disease Testing Products) and Platform (Lateral Flow Assays, Immunoassays), 2022-2027

  • PDF Icon

    Report

  • 77 Pages
  • October 2022
  • Region: Global
  • GlobalData
  • ID: 5693578
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The point-of-care diagnostics market size was valued at US$36.99 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 11.92% during 2022-2027. The point-of-care diagnostics market report provides an executive-level overview of the point-of-care diagnostics market worldwide today, with detailed forecasts of key indicators up to 2027.

This market intelligence report offers a thorough, forward-looking analysis of the global point-of-care diagnostics market, and key product and platform stack in a concise format to help executives build proactive and profitable growth strategies.

The point-of-care diagnostics market size was valued at US$36.99 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 11.92% during 2022-2027. The key to the growth has been the high prevalence of infectious diseases and growing investment and funding for product development. Additionally, key strategic partnerships and mergers and acquisitions are expected to accelerate market growth. Over the forecast period, the market will witness an increase in government initiatives, favoring the point-of-care diagnostics market growth.

Scope

  • This report provides overview of addressable market for point-of-care diagnostics market
  • It identifies the key trends impacting growth of the market over the next 12 to 24 months, split into three categories: technology trends, macroeconomic trends, and regulatory trends.
  • It includes global market forecasts for the point-of-care diagnostics industry
  • It include segmental forecasts and vendor snapshot on leading vendors operating in or the point-of-care diagnostics industry

Reasons to Buy

  • This market intelligence report offers a thorough, forward-looking analysis of the global point-of-care diagnostics market and key opportunities in a concise format to help executives build proactive and profitable growth strategies.
  • Accompanying the publisher's Forecast products, the report examines the assumptions and drivers behind ongoing and upcoming trends in point-of-care diagnostics markets.
  • The report also highlights key platform and product segments.
  • With different charts and tables, the report is designed for an executive-level audience, boasting presentation quality.
  • The report provides an easily digestible market assessment for decision-makers built around in-depth information gathered from market players, which enables executives to quickly get up to speed with the current and emerging trends in point-of-care diagnostics markets.

Table of Contents

CHAPTER 01 Executive Summary
1.1 Point-of-Care Diagnostics Market Snapshot
CHAPTER 02 Research Scope and Segmentation
CHAPTER 03 Technology Briefing
3.1 What is point-of-care testing?
3.2 Industry Trends
CHAPTER 04 Point-of-Care Diagnostics Industry Trends Analysis
4.1 Point-of-Care Diagnostics Industry Value Chain
4.1.1 Hematological disorders
4.1.2 Metabolic Disorders
4.2 Point-of-Care Diagnostics Market Structure - PORTER’s Analysis
CHAPTER 05 Global Point-of-Care Diagnostics Revenue Opportunity
5.1 Global Point-of-Care Diagnostics Market
5.2 COVID-19 Impact
CHAPTER 06 Regulatory Overview
6.1 US
6.2 Europe
6.3 Japan
CHAPTER 07 Point-of-Care Diagnostics Products Outlook
7.1 Point-of-Care Diagnostics - Products Deep Dive
7.1.1 Glucose Monitoring Products
7.1.2 Infectious Disease Testing Products
7.1.3 Cardiometabolic Monitoring Products
7.1.4 Pregnancy and Fertility Testing Products
7.1.5 Hematological Products
7.1.6 Others
CHAPTER 08 Point-of-Care Diagnostics Platform Outlook
8.1 Point-of-Care Diagnostics - Platform Deep Dive
8.1.1 Lateral Flow Assays
8.1.2 Immunoassays
8.1.3 Microfluidics
8.1.4 Dipsticks
8.1.5 Molecular Diagnostics
CHAPTER 09 Point-of-Care Diagnostics Regional Outlook
9.1 Point-of-Care Diagnostics - Regional Deep Dive
9.1.1 North America
9.1.2 Europe
9.1.3 Asia-Pacific
9.1.4 ROW
CHAPTER 010 Trends, Drivers, and Challenges
10.1 Point-of-Care Diagnostics - Market Trends
10.1.1 The advent of next-generation point-of-care diagnostics technologies
10.1.2 Approval and authorization of products for COVID-19
10.1.3 Key strategic partnerships and M&A
10.2 Point-of-Care Diagnostics - Market Drivers
10.2.1 High prevalence of infectious diseases
10.2.2 Robust government initiatives
10.2.3 Growing investments and funding for product development
10.3 Point-of-Care Diagnostics - Market Challenges
10.3.1 Disadvantages associated with point-of-care testing
10.3.2 Challenges associated with point-of-care diagnosis implementation
10.3.3 Challenges associated with quality control and result reporting
CHAPTER 011 Global Point-of-Care Diagnostics Competitive Landscape
11.1 Point-of-Care Competitive Landscape
11.2 Point-of-Care Vendor Snapshot
11.2.1 Company snapshot: Abbott Laboratories
11.2.2 Company snapshot: DANAHER CORP.
11.2.3 Company snapshot: F. Hoffmann-La Roche AG
11.2.4 Company snapshot: EKF Diagnostics Holdings plc
11.2.5 Company snapshot: QUIDEL Corp.
11.2.6 Company snapshot: OraSure Technologies Inc.
11.2.7 Company snapshot: SIEMENS HEALTHINEERS AG
11.2.8 Company snapshot: TRINITY BIOTECH PLC
11.2.9 Company snapshot: SYSMEX Corp.
11.2.10 Company snapshot: Becton, Dickinson and Co.
11.2.11 Chembio Diagnostics Inc.
11.2.12 Nova Biomedical
11.2.13 DiaSorin SPA
11.2.14 MERIDIAN BIOSCIENCE INC.
11.2.15 bioMérieux SA
11.2.16 Thermo Fisher Scientific Inc.
11.2.17 Changsha Sinocare Inc.
11.2.18 Werfen SA (Instrumentation Laboratory)
11.2.19 Precision Biosensor Inc.
11.2.20 GeneSTAT Molecular Diagnostics LLC
CHAPTER 012 Appendix
12.1 Abbreviations
12.2 Methodology
12.3 Key Themes Impacting the Pharmaceutical Industry
12.4 About the Publisher
  • Contact the Publisher
List of Tables
Table 1 Key Trends Overview
Table 2 Research scope and segmentation
Table 3 Technology Trends
Table 4 Macroeconomic Trends
Table 5 Global Point-of-Care Diagnostics Market
Table 6 Regulatory Trends
Table 7 Point-of-Care Diagnostics by Products, 2020-2027 ($Mn)
Table 8 Point-of-Care Diagnostics by Platform, 2020-2027 ($Mn)
Table 9 Point-of-Care Diagnostics by Region, 2020-2027 ($Mn)
Table 10 North America Point-of-Care Diagnostics by Country, 2020-2027 ($Mn)
Table 11 Europe Point-of-Care Diagnostics by Country, 2020-2027 ($Mn)
Table 12 Asia-Pacific Point-of-Care Diagnostics by Country, 2020-2027 ($Mn)
Table 13 Competitive Position of Leading Companies
Table 14 Other Major Participants
Table 15 Point-of-Care Diagnostics by Products, 2020-2027 ($Mn)
List of Figures
Figure 1 Market Snapshot ($Mn)
Figure 2 Key Segment Performance Snapshot
Figure 3 Industry value chain analysis
Figure 4 Hematological Disorders: Leaders and Challengers
Figure 5 Metabolic Disorders: Leaders and Challengers
Figure 6 Global Point-of-Care Diagnostics PORTER’s Five Force Analysis
Figure 7 Global Point-of-Care Diagnostics Market - Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 8 Point-of-Care Diagnostics by Products- Market Overview ($Mn)
Figure 9 Point-of-Care Diagnostics by Products Share - 2021 & 2027 (%)
Figure 10 Glucose Monitoring Products Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 11 Infectious Disease Testing Products Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 12 Cardiometabolic Monitoring Products Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 13 Pregnancy and Fertility Testing Products Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 14 Hematological Products Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 15 Other POC Diagnostic Products Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 16 Point-of-Care Diagnostics by Platform- Market Overview ($Mn)
Figure 17 Point-of-Care Diagnostics by Platform Share - 2021 & 2027 (%)
Figure 18 Lateral Flow Assays Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 19 Immunoassays Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 20 Microfluidics Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 21 Dipsticks Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 22 Molecular Diagnostics Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 23 Point-of-Care Diagnostics by Region- Market Overview ($Mn)
Figure 24 Point-of-Care Diagnostics by Region Share - 2021 & 2027 (%)
Figure 25 North America Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 26 Europe Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 27 Asia-Pacific Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 28 ROW Market Revenue Opportunity Forecast, 2020-2027 ($Mn)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • DANAHER CORP.
  • F. Hoffmann-La Roche AG
  • EKF Diagnostics Holdings plc
  • QUIDEL Corp.
  • OraSure Technologies Inc.
  • SIEMENS HEALTHINEERS AG
  • TRINITY BIOTECH PLC
  • SYSMEX Corp.
  • Becton, Dickinson and Co.